Retained Product Pipeline

Home | Sitemap | Login

Marketed Products

Retained Product Pipeline

-	Fosphenytoin

-

-	Topiramate

Partner Product Pipeline

-	Amiodarone

-	Budesonide

-	Clopidogrel

Retained Product Pipeline Six CyDex product candidates with potential value for hospitals and patients

				Stage of Development
		Product Candidate	Indication	PC	P1	P2	P3
Retained Product Candidates		Fosphenytoin IV and IM	Status Epilepticus
		Melphalan IV	Multiple Myeloma
		Topiramate IV	Epilepsy

		3 Additional Products in Preclinical Development
Updated: May 29, 2008

Š2008 CyDex Pharmaceuticals, Inc. • Legal Notice • Privacy Policy